Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-105,870
Closed -$27.2M 778
2025
Q2
$27.2M Buy
105,870
+4,715
+5% +$1.28M 0.08% 227
2025
Q1
$27M Sell
101,155
-8,486
-8% -$2.3M 0.09% 218
2024
Q4
$26M Sell
109,641
-1,478
-1% -$336K 0.08% 231
2024
Q3
$21.6M Sell
111,119
-1,141
-1% -$216K 0.06% 266
2024
Q2
$20.2M Buy
112,260
+6,725
+6% +$1.34M 0.06% 274
2024
Q1
$23.6M Buy
105,535
+8,079
+8% +$2M 0.07% 250
2023
Q4
$24.5M Buy
97,456
+7,828
+9% +$1.73M 0.08% 244
2023
Q3
$21.7M Buy
89,628
+26,524
+42% +$7.36M 0.08% 258
2023
Q2
$21.7M Sell
63,104
-3,458
-5% -$1.06M 0.07% 276
2023
Q1
$18.6M Sell
66,562
-2,048
-3% -$523K 0.06% 306
2022
Q4
$15.3M Sell
68,610
-6,683
-9% -$1.31M 0.06% 353
2022
Q3
$14.3M Sell
75,293
-26,273
-26% -$4.22M 0.06% 355
2022
Q2
$12.6M Buy
101,566
+26,416
+35% +$4.19M 0.05% 385
2022
Q1
$16.7M Buy
75,150
+8,100
+12% +$1.8M 0.05% 391
2021
Q4
$19.3M Sell
67,050
-10,320
-13% -$2.73M 0.05% 369
2021
Q3
$20.6M Sell
77,370
-130
-0.2% -$34.9K 0.06% 328
2021
Q2
$21.2M Buy
77,500
+26,120
+51% +$7.13M 0.06% 331
2021
Q1
$13.9M Sell
51,380
-13,440
-21% -$3.47M 0.04% 438
2020
Q4
$11.3M Buy
64,820
+9,460
+17% +$2.07M 0.04% 477
2020
Q3
$10.8M Sell
55,360
-19,860
-26% -$4.18M 0.04% 431
2020
Q2
$13.5M Sell
75,220
-3,911
-5% -$679K 0.05% 362
2020
Q1
$12.8M Buy
79,131
+4,481
+6% +$755K 0.06% 309
2019
Q4
$12.3M Buy
74,650
+140
+0.2% +$22.3K 0.05% 405
2019
Q3
$10M Buy
74,510
+6,750
+10% +$1.04M 0.04% 472
2019
Q2
$10.8M Buy
67,760
+50,960
+303% +$7.36M 0.04% 454
2019
Q1
$2.47M Buy
16,800
+3,900
+30% +$557K 0.01% 808
2018
Q4
$1.58M Buy
12,900
+9,600
+291% +$1.29M 0.01% 870
2018
Q3
$494K Buy
+3,300
New +$462K ﹤0.01% 1151
2017
Q1
Sell
-20,710
Closed -$1.32M 1310
2016
Q4
$1.32M Buy
+20,710
New +$1.38M 0.01% 848

Other funds holding PEN

Axa's PEN Position: Q3 2025 in Review

Axa sold out of Penumbra (PEN) in Q3 2025, closing a stake of 105,870 shares — an estimated $27.2M sold.

Axa first reported a position in PEN in Q4 2016 and held it in 29 quarters. The position peaked at $27.2M in Q2 2025. 420 funds tracked by Wall St. Rank hold PEN as of Q3 2025.

  • Axa reported no remaining Penumbra position as of Q3 2025 after selling out during the quarter.
  • Axa sold 105,870 Penumbra shares in Q3 2025, an estimated $27.2M.
  • Axa first reported a position in Penumbra in Q4 2016 and held it in 29 quarters.
  • Axa's Penumbra position peaked at $27.2M in Q2 2025.
  • 420 funds tracked by Wall St. Rank held Penumbra as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.